# Tactile Medical Acquires LymphaTech for $6.8M to Expand Lymphedema Portfolio

> ma · REPORTED · 2026-02-17

Tactile Medical (Nasdaq: TCMD) acquired LymphaTech Inc. on February 17, 2026 for an upfront cash payment of $6.8 million plus potential milestone-based consideration, adding LymphaTech's clinically validated digital 3D full-body measurement and monitoring platform to its lymphedema solutions portfolio. The deal is intended to improve disease identification, enable longitudinal monitoring, and support compression garment digitization.

About Tactile Medical: Tactile Medical is a Nasdaq-listed medical technology company that provides pneumatic compression and other device-based therapies to patients with chronic lymphedema and related disorders.

- Company: Tactile Medical
- Sector: medical devices
- Primary source: https://investors.tactilemedical.com/news-releases/news-release-details/tactile-medical-acquires-lymphatech-expanding-breadth-and-depth

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.